These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Indirect sympatholytic actions at β-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists. Hudson BD; Beazley M; Szczesniak AM; Straiker A; Kelly ME J Pharmacol Exp Ther; 2011 Dec; 339(3):757-67. PubMed ID: 21885619 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat. Pinar-Sueiro S; Zorrilla Hurtado JÁ; Veiga-Crespo P; Sharma SC; Vecino E Exp Eye Res; 2013 May; 110():55-8. PubMed ID: 23454099 [TBL] [Abstract][Full Text] [Related]
13. Positive allosteric modulation of the cannabinoid CB Green HM; Manning JJ; Greig IR; Ross RA; Finlay DB; Glass M Br J Pharmacol; 2024 Oct; 181(19):3642-3662. PubMed ID: 38831545 [TBL] [Abstract][Full Text] [Related]
14. Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2. Song ZH; Slowey CA J Pharmacol Exp Ther; 2000 Jan; 292(1):136-9. PubMed ID: 10604940 [TBL] [Abstract][Full Text] [Related]
15. Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg. Roebuck AJ; Greba Q; Smolyakova AM; Alaverdashvili M; Marks WN; Garai S; Baglot SL; Petrie G; Cain SM; Snutch TP; Thakur GA; Hill MN; Howland JG; Laprairie RB Neuropharmacology; 2021 Jun; 190():108553. PubMed ID: 33845076 [TBL] [Abstract][Full Text] [Related]
16. Evidence that cannabinoid CB1 receptors regulate intraocular pressure via two opposing mechanisms. Miller S; Daily L; Ploss M; Greig I; Ross R; Rayana NP; Dai J; Sugali CK; Mao W; Straiker A Exp Eye Res; 2020 Nov; 200():108241. PubMed ID: 32941875 [TBL] [Abstract][Full Text] [Related]
17. A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects. Ignatowska-Jankowska BM; Baillie GL; Kinsey S; Crowe M; Ghosh S; Owens RA; Damaj IM; Poklis J; Wiley JL; Zanda M; Zanato C; Greig IR; Lichtman AH; Ross RA Neuropsychopharmacology; 2015 Dec; 40(13):2948-59. PubMed ID: 26052038 [TBL] [Abstract][Full Text] [Related]